Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

02126 JW Therapeutics Co.Ltd

3.120
-0.040-1.27%
Closed 10/03 16:08 CCT
High
3.250
Open
3.120
Turnover
974.39K
Low
3.080
Pre Close
3.160
Volume
309.50K
Market Cap
1.28B
P/E(TTM)
Loss
52wk High
15.880
Shares
411.03M
P/E(Static)
Loss
52wk Low
3.060
Float Cap
1.28B
Bid/Ask %
62.69%
Historical High
52.800
Shs Float
411.03M
Volume Ratio
0.59
Historical Low
3.060
Dividend TTM
--
Div Yield TTM
--
P/B
0.42
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.08%
Amplitude
5.38%
Avg Price
3.148
Lot Size
500
Float Cap
1.28B
Bid/Ask %
62.69%
Historical High
52.800
Shs Float
411.03M
Volume Ratio
0.59
Historical Low
3.060
Dividend TTM
--
P/B
0.42
Dividend LFY
--
Turnover Ratio
0.08%
Amplitude
5.38%
Avg Price
3.148
Lot Size
500
Price Forecast

No Data

News

Comment

Company Overview More
Yao Ming Junuo (Cayman) Co., Ltd. is a Chinese company mainly engaged in clinical and preclinical cell therapy. The company is committed to developing cell therapy for the Chinese market and bringing new treatments to Chinese cancer patients. Through its subsidiaries, it has established an integrated platform focused on the development, manufacture and commercialization of breakthrough cellular immunotherapy for hematological cancer and solid tumors. Its main candidate product, relmacabtagene autoleucel (relma-cel), is autologous anti-CD19 CAR-T therapy for recurrent or refractory B-cell lymphoma. The company mainly does business in the Chinese market.
CEO: Yiping Li
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...